Viridian Therapeutics, Inc.\DE (VRDN) Other Non Operating Income (2026)

Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Other Non Operating Income came in at $7.5 million in Q1 2026.

Viridian Therapeutics, Inc.\DE (VRDN) Other Non Operating Income (2026) Analysis & Trends

Viridian Therapeutics, Inc.\DE's Other Non Operating Income history runs 1 years deep, the most recent figure standing at $7.5 million for Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-
10	Viridian Therapeutics, Inc.\DE	631.55 Mn	631.55 Mn	-

Download Data

Date	Value
Mar 31, 2026	7.53 Mn